Amber Rose Keenan, FNP

Amber Keenan practices at North Bay Allergy and Asthma Associates Inc. in Napa, California.

Amber Keenan's NPI, 1972022465, was assigned on September 15, 2017. Amber Keenan holds California license 95007120.

Amber Keenan's primary practice is North Bay Allergy and Asthma Associates Inc., at 1100 Pear Tree Ln, Napa, CA 94558 in Napa County. The practice phone is (707) 258-8100.

Amber Keenan's primary practice is North Bay Allergy and Asthma Associates Inc. in Napa, California. The medical group on file is North Bay Allergy and Asthma Associates. Dmand AI also links Amber Keenan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amber Keenan practices. Vendor and product names are available with a free account.

Nurse practitioner is Amber Keenan's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Amber Keenan is licensed in California.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic obstructive pulmonary disease (COPD), chronic sinusitis, conjunctivitis, eyelid inflammation and hives among the conditions Amber Keenan treats.

CMS data shows 251 Medicare services from Amber Keenan across 5 procedure codes in 2024, for 102 Medicare patients. Medicare paid $15,144 for them. Every service was in an office.

CMS counts 102 Medicare patients who saw Amber Keenan in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 19% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Amber Keenan's median patient age at 39, with 66% women.

In 2024, Amber Keenan wrote 375 Medicare Part D claims for 79 patients. 60% of them were for generic drugs. CMS names the drug for 256 of them, across 10 drugs with 11 or more claims each, at $55,051 in total drug cost.

Amber Keenan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Amber Keenan as offering telehealth.

CMS Open Payments shows 55 general payments to Amber Keenan from 13 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $407.